Loading…
Loading…
OSCR does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for OSCR and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for OSCR and 80,000+ other tickers.
See exactly how OSCR's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OSCR and 80,000+ other tickers.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
Oscar Health (OSCR), a health insurer focused on the individual market, will enter South Carolina and expand to 713 counties across 21 states for 2027, a 24% in
Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects, a more attractive valuation and robust stock gains.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $33.47, representing a -2.48% change from its previous close.
Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.
Oscar Health trades ~13% below its 2021 IPO price, even though management expects 2026 revenue at ~7X its 2021 level. The expiry of enhanced ACA subsidies has always been the main bear case, and it already happened: OSCR grew members ~60% while the ACA market shrank ~13%. For 2027, I see competitor exits, double digit price increases, and consensus EPS below management's own targets as the setup for a rerate.